Catalyst Wire Dossier Catalyst Wire Dossier

W-3 polyunsaturated fatty acids

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for W-3 polyunsaturated fatty acids, covering 2021-02-10 to 2021-02-10. Get the full timeline:

Most recent: Clinical Trial Update: Effect of W-3 Polyunsaturated Fatty Acids on Serum Albumin Concentration in Patients With Acute Heart Failure, Hypoalbuminemia, and High Inflammatory Activity [Phase 3]

See pricing